We are live on ! Find out more
CCM

Cribstone Capital Management Portfolio holdings

AUM $172M
1-Year Est. Return 13.58%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
-13.58%
3 Year Est. Return
+22.36%
5 Year Est. Return
+42%
10 Year Est. Return
AUM
$180M
AUM Growth
+$12.4M
Cap. Flow
+$2.14M
Cap. Flow %
1.19%
Top 10 Hldgs %
37.13%
Holding
445
New
38
Increased
104
Reduced
57
Closed
13
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPCE icon
376
Virgin Galactic
SPCE
$398M
$1K ﹤0.01%
2
UL icon
377
Unilever
UL
$136B
$1K ﹤0.01%
9
KRTX
378
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1K ﹤0.01%
10
ALL icon
379
Allstate
ALL
$67.5B
$0 ﹤0.01%
3
+1
+50% +$118
BHF icon
380
Brighthouse Financial
BHF
$3.5B
$0 ﹤0.01%
9
+6
+200% +$307
BZUN
381
Baozun
BZUN
$172M
$0 ﹤0.01%
8
CCJ icon
382
Cameco
CCJ
$42.4B
$0 ﹤0.01%
15
CLX icon
383
Clorox
CLX
$12.7B
$0 ﹤0.01%
2
-4
-67% -$667
EEM icon
384
iShares MSCI Emerging Markets ETF
EEM
$30B
$0 ﹤0.01%
2
FAF icon
385
First American
FAF
$7.58B
$0 ﹤0.01%
2
FBIN icon
386
Fortune Brands Innovations
FBIN
$6.06B
-23
Closed -$2K
FLRN icon
387
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.97B
-33
Closed -$1K
GLAD icon
388
Gladstone Capital
GLAD
$446M
$0 ﹤0.01%
8
IRDM icon
389
Iridium Communications
IRDM
$5.29B
$0 ﹤0.01%
+10
New +$404
JOBY icon
390
Joby Aviation
JOBY
$8.55B
-1,000
Closed -$10K
LCID icon
391
Lucid Motors
LCID
$2.77B
-1
Closed
LCTX icon
392
Lineage Cell Therapeutics
LCTX
$278M
$0 ﹤0.01%
+88
New +$206
LMND icon
393
Lemonade
LMND
$4.1B
-2,000
Closed -$134K
LMT icon
394
Lockheed Martin
LMT
$136B
$0 ﹤0.01%
1
NTSX icon
395
WisdomTree US Efficient Core Fund
NTSX
$1.4B
$0 ﹤0.01%
+7
New +$302
OGN icon
396
Organon & Co
OGN
$3.57B
$0 ﹤0.01%
4
-464
-99% -$15.1K
OSUR icon
397
OraSure Technologies
OSUR
$279M
-25
Closed
OXY.WS icon
398
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$0 ﹤0.01%
7
PEBO icon
399
Peoples Bancorp
PEBO
$1.47B
$0 ﹤0.01%
15
ROK icon
400
Rockwell Automation
ROK
$49B
-7
Closed -$2K

Similar funds

Cribstone Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Cribstone Capital Management held 445 positions worth $180M, up 7.4% from $168M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Cribstone Capital Management's Q4 2021 filing shows 38 new, 104 increased, 57 reduced and 13 closed positions. Its largest new stake was Moderna: 800 shares worth $203K. The largest sale was iShares iBonds Dec 2021 Term Corporate ETF, an estimated $3.62M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.

  • Cribstone Capital Management's largest Q4 2021 buy was Moderna: 800 shares worth $203K.
  • Cribstone Capital Management added most to iShares iBonds Dec 2025 Term Corporate ETF in Q4 2021, an estimated $1.55M increase.
  • Cribstone Capital Management's biggest Q4 2021 reduction was AT&T, cutting an estimated $823K.
  • Cribstone Capital Management fully exited iShares iBonds Dec 2021 Term Corporate ETF in Q4 2021, selling an estimated $3.62M.
  • Cribstone Capital Management's ten largest holdings make up 37% of its $180M portfolio in Q4 2021.
  • Cribstone Capital Management opened 38 new positions and closed 13 in Q4 2021.
  • Cribstone Capital Management's portfolio value rose 7.4% quarter-over-quarter to $180M.

Based on Cribstone Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.